Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr Sherri's statement of "Virtually No Side Effects"

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Mar 17, 2022 2:51pm

190 Views

Post# 34522845

RE:RE:Dr Sherri's statement of "Virtually No Side Effects"

No way TLT can avoid cutting a deal with a big Pharma. Why? Because it doesn't a network of distribution and it would cost way too much to develop one and it would take too long anyway.

BioNtech jv with Pfizer in 2018. In 2019, its IPO was worth 3.4B$. BioNTech valuation went up to 67B$ before pulling back to 37B$. So big pharmas can help provide valuation much faster than going alone. That's a no brainer. Just an upfront payment from a big Pharma would spike our share price instantly.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?